Red Flags Detected

  • Material Weakness (new) — Company newly disclosed a material weakness in internal controls over financial reporting related to insufficient segregation of duties that was not present in the prior period.
NASDAQ: NMTC NEUROONE MEDICAL TECHNOLOGIES Corp 10-Q

NeuroOne discloses material weakness in controls, regains Nasdaq compliance after reverse split

Filed May 12, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade NMTC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.